• EN

EMCDDA–Europol 2010 Annual Report on the implementation of Council Decision 2005/387/JHA

EMCDDA-Europol, Lisbon, May 2011

Publication type:

Implementation reports


This report presents the results and outlines the key achievements for 2010 on the information exchange, risk-assessment and control of new psychoactive substances.

In 2010, 41 new psychoactive substances were officially notified for the first time in the European Union through the Early-Warning System (EWS). Of those, 15 were synthetic cathinones and 11 were synthetic cannabinoids. Substances belonging to more established chemical families were also reported – five phenethylamines, one tryptamine and one piperazine. The list of newly notified substances was rather diverse and also included a plant-based substance, a synthetic cocaine, a ketamine derivative, a phencyclidine derivative, an indane, a benzofuran, as well as a substance which can be seen as a designer medicine.

The report also describes the increased availability of 'legal highs' and the EMCDDA's activities in monitoring the online shops selling these products, as well as the risk assessment of mephedrone, which was submitted to control measures and criminal penalties throughout the European Union.

Download as pdf (683Kb):

English (en)

Table of contents

  • 1. Introduction and background
  • 2. Implementation arrangements and cooperation with the EU pharmacovigilance system
  • 3. Results achieved in 2010
  • 4. Key developments in the period 2005–10
  • 5. Outlook on future challenges
  • 6. Conclusion
  • Annexes





About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Tel. (351) 211 21 02 00

More contact options >>

Page last updated: Thursday, 26 April 2012